Pear Tree Pharmaceuticals, Inc.

Waltham, MA 02451

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $221K
First Award Date 06/01/12
Most Recent Award Date 06/01/12

Key Personnel

Last Name Name Awards Contact
Mermelstein Fred Mermelstein 1

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 06/01/12 - 11/30/13

DESCRIPTION (provided by applicant): The goal of this project is to study and validate the tolerability of vaginally-administered PT-101, a novel low dose formulation of Tamoxifen Citrate for vaginal administration. PT-101 was designed to treat vulvovaginal atrophy (VVA), a condition associated with aging, menopause and breast cancer treatment. ...